Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 2,470 shares (to pay taxes)
  2. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $76.80 ($38,400)
  3. 4 Shares withheld for taxes SVP & CFO gave up 5,277 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP & CFO gave up 5,503 shares (to pay taxes)
  5. 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 3,011 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 3,017 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP - CORP. DEV. & STRATEGY gave up 4,269 shares (to pay taxes)
  8. 4 Shares withheld for taxes SVP, GENERICS gave up 4,267 shares (to pay taxes)
  9. 4 Shares withheld for taxes PRESIDENT & CEO gave up 30,659 shares (to pay taxes)
  10. 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 4,546 shares (to pay taxes)
  11. 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 1,762 shares (to pay taxes)
  12. 4 Shares withheld for taxes HEAD OF R&D, COO-NOVITIUM OPS gave up 2,898 shares (to pay taxes)
  13. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $84.33 ($42,165)
  14. 4 Planned sale SVP, CHIEF HR OFFICER sold 1,622 shares at $82.40 ($133,653)
  15. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $82.32 ($32,928)
  16. 4 Open-market sale Director sold 1,800 shares at $81.15 ($146,070)
  17. 4 Open-market sale Director sold 8,643 shares at $86.88 ($750,904)
  18. 4 Open-market sale SVP - CORP. DEV. & STRATEGY sold 14,736 shares at an average $89.06 ($1,312,435)
  19. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $87.27 ($34,908)
  20. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $90.09 ($36,036)

Page 4 of 42 · 834 filings